China's New Trade War Defense Is a Stock Market for Tech Firms
- New Shanghai tech board expected to start in coming weeks
- China under pressure to bolster technology supply chain
This article is for subscribers only.
In a nondescript building in a Beijing suburb, workers stitch bovine and porcine tissue into replacement heart valves for humans. Orders are mounting, and founder Jin Lei is looking to the latest feature of Chinese President Xi Jinping’s financial reform to help him expand.
For Jin’s company, Balance Medical Technology Co., selling shares on China’s newest trading venue could fund a 16,000 square-meter facility with a research center, boosting production eightfold to more than 8,000 valves a year. That would take his 14-year-old business one step closer to Edward Lifesciences Corp., the $36 billion U.S. giant Jin calls his model.